LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,008 | -95.6% | 14 | -90.7% | 0.00% | -100.0% |
Q1 2021 | $23,000 | +53.3% | 150 | 0.0% | 0.00% | – |
Q4 2020 | $15,000 | +7.1% | 150 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $14,000 | -17.6% | 150 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $17,000 | +54.5% | 150 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $11,000 | -31.2% | 150 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $16,000 | -61.0% | 150 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $41,000 | +173.3% | 150 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $15,000 | – | 150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |